Vivera BioSciences is focused on developing a selection of medications for various indications, including cardiovascular and central nervous system conditions and fluency disorders. The division centers around using TABMELT, a novel, patented, and patent-pending sublingual drug delivery system that allows patients to take a medication by dissolving a tablet under the tongue. This delivery route may lead to more instantaneous and accurate absorption than oral drug delivery. 

Visit to learn more.